How should I treat a patient with acute idiopathic Bell's palsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Idiopathic Bell's Palsy

Immediate Treatment: Corticosteroids Within 72 Hours

Start oral corticosteroids within 72 hours of symptom onset for all patients ≥16 years old—this is the only proven treatment that significantly improves facial nerve recovery. 1

Recommended Steroid Regimens (Choose One):

  • Prednisolone 50 mg once daily for 10 days (no taper needed), OR 1
  • Prednisone 60 mg once daily for 5 days, followed by a 5-day taper 1

Evidence Supporting Steroids:

  • 83% complete recovery at 3 months with prednisolone vs. 64% with placebo (NNT = 6) 1
  • 94% complete recovery at 9 months with prednisolone vs. 82% with placebo (NNT = 8) 1
  • No benefit if started after 72 hours—the treatment window is critical 1, 2

Antiviral Therapy: Limited Role

Never prescribe antivirals alone—they are completely ineffective as monotherapy and delay appropriate corticosteroid treatment. 1, 2

Optional Combination Therapy:

  • May add valacyclovir 1 g three times daily for 7 days OR acyclovir 400 mg five times daily for 10 days to steroids within 72 hours 1
  • Provides modest additional benefit: 96.5% recovery with combination vs. 89.7% with steroids alone (absolute benefit +6.8%) 1
  • This is classified as an "option" rather than a recommendation due to the small incremental gain 1

Eye Protection: Mandatory for All Patients with Impaired Eye Closure

Implement aggressive eye protection immediately to prevent permanent corneal damage—this is non-negotiable. 1, 2

Specific Eye Protection Measures:

  • Lubricating eye drops every 1-2 hours while awake 1
  • Ophthalmic ointment at bedtime for sustained moisture 1
  • Eye taping or patching at night with careful instruction on proper technique to avoid corneal abrasion 1
  • Sunglasses outdoors to protect against wind and debris 1
  • Urgent ophthalmology referral if severe impairment with complete inability to close the eye 1

Diagnostic Testing: What NOT to Do

Do not order routine laboratory tests or imaging for typical Bell's palsy—they delay treatment without improving outcomes. 1, 2

When to Consider Testing:

  • MRI with and without contrast only for atypical features: 1

    • Bilateral facial weakness
    • Isolated branch paralysis (forehead spared)
    • Other cranial nerve involvement
    • Progressive weakness beyond 3 weeks
    • No recovery after 3 months
    • Recurrent paralysis on the same side
  • Electrodiagnostic testing (ENoG/EMG) may be offered only to patients with complete facial paralysis at 3-14 days post-onset 1

    • Not recommended for incomplete paralysis 1
    • 10% nerve response amplitude = excellent prognosis 1

    • <10% function = up to 50% risk of incomplete recovery 1

Follow-Up and Referral Triggers

Mandatory 3-Month Reassessment:

Refer to a facial nerve specialist if facial recovery is incomplete at 3 months after symptom onset. 1, 2

Urgent Referral at Any Time Point:

  • New or worsening neurologic findings (suggests alternative diagnosis like stroke, tumor, or CNS pathology) 1
  • Development of ocular symptoms (requires ophthalmology referral to prevent corneal damage) 1
  • Progressive weakness beyond 3 weeks (red flag for alternative diagnosis) 1

Special Populations

Children:

  • Better prognosis than adults with higher spontaneous recovery rates (up to 94%) 1
  • Steroid benefit is inconclusive in pediatric patients—no high-quality pediatric-specific trials exist 1
  • Consider prednisolone 1 mg/kg/day (max 50-60 mg) for severe/complete paralysis after shared decision-making with caregivers 1

Pregnant Women:

  • Treat with oral corticosteroids within 72 hours using individualized risk-benefit assessment 1
  • Pregnancy is not a contraindication to steroids 1
  • Eye protection measures are essential and safe in pregnancy 1

Diabetic Patients:

  • Diabetes is not a contraindication to corticosteroids—the therapeutic benefit outweighs the risk of temporary hyperglycemia 1
  • Monitor capillary blood glucose every 2-4 hours during the first few days of steroid therapy 1
  • Proactively adjust diabetes medications: increase basal insulin and add/increase prandial insulin 1
  • Consider adding NPH insulin concurrent with morning steroid dose (peaks 4-6 hours later, matching hyperglycemic effect) 1

Prognosis and Natural History

Expected Recovery Timeline:

  • Incomplete paralysis at presentation: up to 94% complete recovery 1, 3
  • Complete paralysis: approximately 70% complete recovery within 6 months 1
  • Most patients begin showing recovery within 2-3 weeks 1
  • Complete recovery typically occurs within 3-4 months 1

Poor Prognostic Factors:

  • Complete paralysis at presentation 3
  • ENoG showing <10% nerve response amplitude 1
  • Age >60 years 4
  • Diabetes mellitus 4

Interventions NOT Recommended

Do not offer the following—they lack proven benefit or have insufficient evidence: 1, 2, 5

  • Physical therapy: no proven benefit over spontaneous recovery 1
  • Acupuncture: poor-quality trials with indeterminate benefit-harm ratio 1
  • Electrical nerve stimulation: no specific recommendation due to lack of evidence 5
  • Surgical decompression: not advised except in rare, highly selected cases at specialized centers 1

Critical Pitfalls to Avoid

  1. Delaying steroids beyond 72 hours eliminates their effectiveness 1, 2
  2. Using antiviral monotherapy is completely ineffective and delays appropriate treatment 1, 2
  3. Inadequate eye protection can lead to permanent corneal damage 1
  4. Failing to refer at 3 months delays access to reconstructive options 1
  5. Missing atypical features (bilateral weakness, forehead sparing, other cranial nerve involvement) suggests alternative diagnoses requiring imaging 1
  6. Ordering routine labs/imaging for typical presentations increases costs without benefit 1, 2

References

Guideline

Assessment and Management of Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The management of peripheral facial nerve palsy: "paresis" versus "paralysis" and sources of ambiguity in study designs.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2010

Research

Bell's Palsy.

Continuum (Minneapolis, Minn.), 2017

Guideline

Electric Nerve Stimulation in Bell's Palsy Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.